Since publication of the original article the authors noticed two author names were displayed incorrectly. Maryanne Zilli Canedo da Silva should be Maryanne Zilli Canedo Silva, and Nayrana Soares do Carmo Reis should be Nayrana Soares Carmo Reis. Furthermore, since publication of the original article an erratum regarding the European consensus on sarcopenia was published [1]. This affected the original article's results in several ways. The results affected are listed below. Abstract "The prevalence of sarcopenia ranged from 4 to 10% according to cut points and references used" should read "The prevalence of sarcopenia remained 4% according to cut points and references used." Materials and methods Diagnosis of sarcopenia "Values below 7 kg/m² for men and 6 kg/m² for women were considered as decreased muscle mass and confirmation of the presence of sarcopenia [3]" should read "Values below 7 kg/m² for men and 5.5 kg/m² for women were considered as decreased muscle mass and confirmation of the presence of sarcopenia [3]." Results Table 1 was not affected by the change in results and is reproduced here: "Prevalence of sarcopenia according to the 2019 EWGSOP criteria was 10% (n = 5). Reduced muscle mass alone was prevalent in 20% (n = 10) and reduced muscle function assessed by HGS was frequent in 28% (n = 14)" should read "Prevalence of sarcopenia according to the 2019 EWGSOP criteria was 4% (n = 2). Reduced muscle mass alone was prevalent in 10% (n = 5) and reduced muscle function assessed by HGS was frequent in 28% (n = 14)." Figure 1 was affected by the change in results. Both the original Fig. 1 and updated Fig. 1 are produced below: Fig. 1 Prevalence of isolated reduced muscle mass and muscle function, and sarcopenia in PD patients (original).
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